Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Chief Commercial Officer | Common Stock | 127K | $3.21M | $25.28 | Jul 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jul 2, 2024 | 1 | -$237K | 4 | Jul 3, 2024 | Chief Commercial Officer |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 4, 2024 | 2 | -$2.51K | 4 | Jan 8, 2024 | Chief Commercial Officer |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jul 3, 2023 | 1 | -$315K | 4 | Jul 6, 2023 | Chief Commercial Officer |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jan 4, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Commercial Officer |
ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Jun 20, 2022 | 0 | $0 | 3 | Jun 29, 2022 | Chief Commercial Officer |